We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2303:TWSEUnited Microelectronics Corp. Analysis

Data as of 2026-06-12 - not real-time

NT$133.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

United Microelectronics is riding a bullish market trend, with prices comfortably above both short‑term and mid‑term moving averages, yet the momentum indicators are turning negative – the MACD histogram sits below zero and the RSI is perched in the upper half of its range. Volatility is exceptionally high, and the stock’s beta is low, suggesting price swings are driven more by sector dynamics than broad market moves. The discounted cash‑flow model places fair value well below the current trading level, implying a sizable downside potential. Fundamentally, revenue is growing modestly, margins remain healthy, and the balance sheet is strong with abundant cash and modest leverage. The dividend yield is modest but the payout ratio is high, which the strong cash flow currently supports. However, the semiconductor sector’s cyclical nature and Taiwan’s geopolitical exposure add layers of uncertainty.
Given the overvalued pricing, elevated volatility, and downside bias from valuation models, short‑term investors may consider trimming exposure, while medium‑term participants might adopt a wait‑and‑see stance. Over the longer horizon, the company’s solid fundamentals and dividend policy could provide a stable platform, but only if valuation compresses and external risks ease.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price significantly above fair value
  • negative MACD momentum
  • extremely high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong cash position and low leverage
  • moderate revenue growth
  • persistent sector cyclicality

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • sustainable dividend supported by cash flow
  • potential valuation compression
  • geopolitical and regulatory exposure in Taiwan

Key Metrics & Analysis

Financial Health

Revenue Growth5.50%
Profit Margin20.82%
P/E Ratio33.9
ROE12.52%
ROA4.83%
Debt/Equity18.69
P/B Ratio4.1
Op. Cash FlowNT$98.0B
Free Cash FlowNT$34.4B
Industry P/E36.7

Technical Analysis

TrendBullish
RSI59.7
SupportNT$103.50
ResistanceNT$155.50
MA 20NT$127.38
MA 50NT$97.22
MA 200NT$62.37
MACDBearish
VolumeIncreasing
Fear & Greed Index87.89

Valuation

Fair ValueNT$49.86
Target PriceNT$83.60
Upside/Downside-37.38%
GradeOvervalued
TypeBlend
Dividend Yield2.28%

Risk Assessment

Beta0.48
Volatility90.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.